Overview

A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA)

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if CH-4051 is a safe and effective treatment for rheumatoid arthritis.
Phase:
Phase 2
Details
Lead Sponsor:
Chelsea Therapeutics
Treatments:
Folic Acid
Methotrexate
Vitamin B Complex